EpiStem Holdings plc
Description
EpiStem provides interactive and intelligent pre-clinical solutions to assist companies in the development of novel therapies for proliferative disease.
Stock Ticker
EHP
Chairman
David Evans
CEO
Matthew Walls
FD
John Rylands
Latest Headlines for EpiStem Holdings plc
Epistem upbeat as value opportunities begin to emerge Thursday, February 28, 2008
EpiStem completes first year of biodefense drug test programmeFriday, September 21, 2007
EpiStem completes AIM listingWednesday, April 04, 2007
|
Share Data
(15 minutes delayed)
| Latest trade time | n/a | | Share Price | 210.00 | | Change Today | 0.00 | | % Change Today | 0.00 | | Volume | 0 | | Today High | 210.00 | | Today Low | 195.00 | | 52 Week High | 212.50 | | 52 Week Low | 148.50 | No. of shares
in issue | 7m | | Market Capitalisation | £14.7m |
This is a solution provided by Digital Look Corporate
Solutions
incorporating their prices and data, on this site.
Terms & Conditions
|
|